Dynamic Kv4.3-CaMKII unit in heart: an intrinsic negative regulator for CaMKII activation

Eur Heart J. 2011 Feb;32(3):305-15. doi: 10.1093/eurheartj/ehq469. Epub 2010 Dec 8.

Abstract

Aims: Reduction of transient outward current (I(to)) and excessive activation of Ca(2+)/Calmodulin-dependent kinase II (CaMKII) are general features of ventricular myocytes in heart failure. We hypothesize that alterations of I(to) directly regulate CaMKII activation in cardiomyocytes.

Methods and results: A dynamic coupling of I(to) channel subunit Kv4.3 and inactive CaMKII was discovered in cardiomyocytes with the membrane predominant distribution by co-immunoprecipitation and fluorescence resonance energy transfer techniques. CaMKII dissociation from Kv4.3-CaMKII units caused a significant increase in CaMKII autophosphorylation and L-type calcium current (I(Ca)) facilitation. I(Ca) facilitation was blunted by the compartmental Ca²(+) chelator BAPTA but unaffected by bulk Ca²(+) chelator EGTA, implicating membrane-localized CaMKII. Kv4.3 overexpression reduced basal CaMKII autophosphorylation in myocytes and eliminated Ca²(+)-induced CaMKII activation. Kv4.3 blocks CaMKII activation by binding to the calmodulin binding sites, whereas Kv4.3 uncoupling releases these sites and leads to a substantial CaMKII activation.

Conclusion: Our results uncovered an important mechanism that regulates CaMKII activation in the heart and implicate I(to) channel alteration in pathological CaMKII activation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Aminopyridine / pharmacology
  • Animals
  • Calcium / metabolism
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / physiology*
  • Chelating Agents / pharmacology
  • Edetic Acid / pharmacology
  • Egtazic Acid / pharmacology
  • HEK293 Cells
  • Heart Diseases / etiology
  • Heart Diseases / prevention & control
  • Humans
  • Immunoprecipitation
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Myocytes, Cardiac / metabolism*
  • Patch-Clamp Techniques
  • Potassium Channel Blockers / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Shal Potassium Channels / metabolism
  • Shal Potassium Channels / physiology*

Substances

  • Chelating Agents
  • Potassium Channel Blockers
  • Shal Potassium Channels
  • Egtazic Acid
  • Edetic Acid
  • 4-Aminopyridine
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Calcium